Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$760,314
-$71,306 QoQ
Shares Held
6,018
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,197
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglass Winthrop Advisors, LLC holds $62,081,020 across 7 Drug Manufacturers - General names. GILD ranks #7 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,774 | $27,315,821 | |
| 2 | JNJ |
Johnson & Johnson
|
104,526 | $26,546,468 | |
| 3 | AMGN |
Amgen Inc
|
8,961 | $3,244,957 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
27,548 | $1,587,315 | |
| 5 | NVS |
Novartis AG
|
8,755 | $1,372,083 | |
| 6 | PFE |
Pfizer Inc
|
52,079 | $1,254,062 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
6,018 | $760,314 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $760,314 | 6,018 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $831,620 | 5,967 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $732,389 | 5,967 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $995,337 | 8,967 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $681,850 | 6,150 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $728,325 | 6,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $648,899 | 7,025 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $591,072 | 7,050 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $486,993 | 7,098 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $516,412 | 7,050 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $637,953 | 7,875 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $590,152 | 7,875 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $606,926 | 7,875 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $686,576 | 8,275 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $723,286 | 8,425 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $467,301 | 7,575 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $469,756 | 7,600 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $463,710 | 7,800 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $889,472 | 12,250 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $628,650 | 9,000 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $663,948 | 9,642 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $591,364 | 9,150 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $541,818 | 9,300 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $625,581 | 9,900 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $799,791 | 10,395 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $799,109 | 10,689 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||